Skip to main content

EPP Life Sciences Pricing Forum 2024 Program

Pricing for Impact: Innovating for Growth and Sustainability

 

Explore the detailed program here

2-DAY TRAINING 8 October 2024

 

 

TRAINING:

MedTech Pricing Strategies and Tactics   Discover more

Tender WarGame  Discover more

PRE-FORUM WORKSHOPS 9 October 2024

13h00 - 17h00

We are excited to announce that the EPP Life Sciences Pricing Forum 2024 will feature four exclusive workshops led by industry leaders: EVERSANAModel NMonitor Deloitte, and Vistex. These workshops will provide hands-on, practical insights into cutting-edge pricing strategies and solutions. Stay tuned for more details on each workshop and how they will empower you to transform your pricing approach. 

More information will be available soon!

10 October 2024

08h30 - 17h00

Welcome Coffee and Registrations

Welcome by Pol Vanaerde - President - EPP Pricing Platform

Opening Remarks – Negotiating Dangerous Post-Covid Market Dynamics

Session 1:
AI: Intelligent Pricing - AI’s Role in Pharma’s Future

Harnessing Artificial Intelligence to Drive Profitability & Innovation in Life Sciences

AI-Driven Dynamic Pricing - Adapting to Market Demands

Alan Crowther - General Manager Global Pricing - EVERSANA

Machine Learning in Market Access - A Game-Changer

Sandro Cesaro - Head of Market Access & Innovative Value Strategies, Oncology Europe & Canada - AstraZeneca

AI-Driven Reimbursement and Negotiation in Pharma

Gianclaudio Floria - Founder, Forecasting & Market Access - Brightlight Consulting 
Chirag Maheshwari - Co-Founder & Director - Brightlight Consulting 

The Use of AI in Assessing the Value of New Drugs

Marc Abels - Partner - MONITOR DELOITTE

BREAKOUT SESSIONS:

BREAKOUT 1


    BREAKOUT 2

AI Unleashed: Gen AI and Drug Pricing Revolution

    Generative AI: Simulating Market Scenarios for Strategic Pricing

AI Forecasting for Strategic Pricing Decisions

“Ask Me About” Lunch & Networking – Be back in 60 minutes

Session 2:
DATA: Decoding Data - The New Currency of Pricing

Empowering Data-Driven Decisions for Competitive Pricing in Life Sciences

Outcome-Based Tendering and Risk Sharing: Forging Win-Win Partnerships in Healthcare 

Raphael Prynk - EMEA Pricing Strategy Leader Cardiac Surgery - Medtronic

How Real-World Evidence Is Transforming Pricing Programs and Access Strategies

Giancarlo Parlato - Head of Global Pricing Excellence - SERVIER PHARMA

Scoring a Winning Goal in Pharma Pricing: Insights from Spain's Football Victory 

Alejandra Garitonandia - LS Industry Principal EMEA - Vistex 

Coffee Break – be back in 30 minutes!

Gross-To-Net Optimizations in Theory and Practice - For Patients and Optimized Profit

Christian Raadmand Jensen - Senior Director Global Pricing - Lundbeck 
Clara Hinsch - Global Pricing Manager - Lundbeck 
Jacob Petersen - Senior Global Pricing Manager - Lundbeck 
Timo Vesterdal - Senior Global Pricing Manager - Lundbeck

Session 3:
INNOVATION: Pricing Reimagined - Innovative Models Shaping the Life Sciences

Exploring the Frontier of Value-Based and Outcome-Driven Pricing Models

Pricing For Radical Innovation in an Incremental Environment

Value-based pricing in the Hearing Instruments industry: Linking theory to practice 

Leandro Gandos Brito - Global Director Strategic Pricing - SONOVA

AMA – Ask Me Anything – Featuring Today’s Speakers

Closing Remarks

Networking dinnner

11 October 2024

08h30 - 17h00

Welcome Coffee and Registrations

Opening Remarks

The Political Perspective of Pharma in Europe – Advocacy & Policy 

Emma Eatwell - Global Practice Director - GLOBAL COUNSEL

Marketing Specialized Next Gen Therapies

Putting Your Pricing Team at the Center of R&D Investment Decisions

Sylvie Gabriel - International Market Access - Consultant

Coffee Break – be back in 30 minutes!

BREAKOUT SESSIONS:

BREAKOUT 1  

BREAKOUT 2

PANEL: Risk-Sharing Agreements: Balancing Innovation & Affordability

Giovanni Tafuri - Director EU Market Access -  APELLIS
Loic Gauthier 
- Director Market Access, Intercontinental Region - CSL Behring

          

Exploring Outcome-Based Contracts in Biotech

Youssef Mamour - Sr Director Pricing - GETINGE
    
 

Session 4:
ANIMAL HEALTH: Pricing Pawspectives - Unleashing Revenue Growth in Animal Health

Navigating AI, Bundles, and Segmentation Tailwinds

Beyond Flea Meds: Dive Into Subscription Tiers That Offer Comprehensive Care

Vincent Blankert - Director Commercial Strategy - ZOETIS

Segment-Specific Strategies to Maximize Revenue

“The Magic Key” Lunch & Networking – Be back in 60 minutes

Session 5:
VALUE-BASED PRICING: Price with Purpose - Crafting Value-Based Strategies for Sustainable Success

Implementing value-based pricing models to ensure long-term viability & patient access

Opening Pandora's Box on Innovative Contracting for Pharma, Biotech & Medical Devices

Omar Ali - Value-Based Pricing - VERPORA

Advances in Value-Based Pricing Across Multiple Products

Thomas Happel - Senior Manager Global Pricing - PHILIPS

BREAKOUT SESSIONS:

BREAKOUT 1  

BREAKOUT 2

Beyond the Pill: Value-Based Services in Pharma

Luis E. Marin - Healthcare Innovative Solutions Partner - Breast Cancer - NOVARTIS   

              

Value-Based Pricing & Access for Medical Devices - Pricing & Contracting Optimization Methods

Istvan Szabo - Pricing, Market Access, Growth Strategies - Independent

Coffee Break – be back in 30 minutes!

Risk-Sharing Agreements: Aligning Interests for Better Outcomes

Networking Game Wrap-Up

AMA – Ask Me Anything – Featuring Today’s Speakers

Closing Remarks

Detected timezone